Company · CIK 1567529
KAMADA LTD
| CIK | 1567529 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | L3 |
| Business address | Israel |
| Listed | KMDA (Nasdaq) |
| First annual or quarterly report | 2014-03-26 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298814 | 2026-09-09 | 2026-09-15 | 2 | |
| 333-274443 | 2023-09-11 | 2023-09-14 | 2 | |
| 333-214816 | 2016-11-28 | 2017-08-01 | 4 | |
| 333-187870 | 2013-04-11 | 2013-05-31 | 5 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-15 | EFFECTDeclared effective | 333-298814 | 9999999995-26-002976 |
| 2026-09-09 | F-3Shelf registered | 333-298814 | 0001213900-26-098203 |
| 2023-09-14 | EFFECTDeclared effective | 333-274443 | 9999999995-23-002668 |
| 2023-09-11 | F-3Shelf registered | 333-274443 | 0001213900-23-075568 |
| 2017-08-01 | 424B5Shelf takedown | 333-214816 | 0001178913-17-002198 |
| 2017-07-27 | 424B5Shelf takedown | 333-214816 | 0001178913-17-002151 |
| 2017-07-13 | EFFECTDeclared effective | 333-214816 | 9999999995-17-001804 |
| 2016-11-28 | F-3Shelf registered | 333-214816 | 0001178913-16-007043 |
| 2013-05-31 | 424B4Final prospectus | 333-187870 | 0001144204-13-032683 |
| 2013-05-30 | EFFECTDeclared effective | 333-187870 | 9999999995-13-001666 |
| 2013-05-28 | F-1/AAmendment | 333-187870 | 0001144204-13-031877 |
| 2013-05-15 | F-1/AAmendment | 333-187870 | 0001144204-13-029602 |
| 2013-04-11 | F-1Registration filed | 333-187870 | 0001144204-13-021368 |
| 2013-01-24 | DRSDraft made public | 377-00096 | 0001144204-13-003704 |